Clinical Trial Update: Mesenchymal Stem Cell Administration in the Treatment of Coronary Graft Disease in Heart Transplant Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating mesenchymal stem cell therapy for coronary graft disease in heart transplant patients is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Allograft Vasculopathy
• Coronary Artery Disease

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Coronary Disease, Heart Transplant | Phase 1, Phase 2 | Status: SUSPENDED